Formulating and Delivering Psychedelics: A CDMO’s View on The Possibilities of Psychedelics
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Upperton Pharma Solutions Recognised as One of The Sunday Times Best Places to Work 2026
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2026
Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
DDL 2025 – The Next Chapter in Inhalation
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
The Evolution of Biotech and CDMO Partnerships
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Upperton Pharma Solutions Named Champion Award Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Upperton Completes Build of New £7m Sterile Manufacturing Facility
Upperton completes build of new £7m Nottingham sterile manufacturing facility for parenteral, nasal and pulmonary delivery.
Upperton continues growth with appointment of Lorna Patrick as Chief Operating Officer
Upperton continues growth with appointment of Lorna Patrick as Chief Operating Officer
Upperton to Attend DCAT Week in New York, 16-19 March
Upperton will attend DCAT Week 2025, Nikki Whitfield, CEO, and Ian Lafferty, CTO, will represent Upperton during the event.
Upperton honoured at Sunday Times 100 Fastest Growing Companies Ceremony
Upperton honoured at Sunday Times 100 Fastest Growing Companies ceremony.